Stay updated with breaking news from Gmab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Genmab A/S (NASDAQ:GMAB – Get Free Report)’s stock price gapped up before the market opened on Thursday . The stock had previously closed at $29.30, but opened at $30.32. Genmab A/S shares last traded at $30.41, with a volume of 35,398 shares traded. Analysts Set New Price Targets Several research analysts have recently weighed in […] ....
Truist Financial restated their buy rating on shares of Genmab A/S (NASDAQ:GMAB – Free Report) in a report released on Tuesday morning, Benzinga reports. Truist Financial currently has a $50.00 target price on the stock. GMAB has been the subject of several other reports. Citigroup lowered Genmab A/S from a neutral rating to a sell […] ....
Genmab A/S (NASDAQ:GMAB – Get Free Report) has received a consensus recommendation of “Hold” from the thirteen ratings firms that are presently covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a sell recommendation, two have issued a hold recommendation and eight have issued a buy recommendation on the company. The average […] ....
BMO Capital Markets upgraded shares of Genmab A/S (NASDAQ:GMAB – Free Report) from a market perform rating to an outperform rating in a research report report published on Friday morning, Marketbeat.com reports. The firm currently has $48.00 price objective on the stock, up from their prior price objective of $46.00. Other research analysts have also […] ....
Mckinley Capital Management LLC reduced its position in Genmab A/S (NASDAQ:GMAB – Free Report) by 34.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,058 shares of the company’s stock after selling 4,295 shares during the period. Mckinley Capital Management […] ....